Skip To Main Content
Barry Rosen on Muck Rack

Barry Rosen

As seen in: Forbes, The Telegraph, TIME, USA Today, Washington Post Opinions, Yahoo News, Yahoo News Malaysia, Aol, Fox News, Newsweek and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry

Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Barry S. Rosen | Authors | CancerNetwork

|
By Barry Rosen
| ONCOLOGY journal Verified
Articles by Barry S. Rosen In a retrospective multi-institution study of 267 early-stage breast cancer patients, the TumorSight Viz AI algorithm achieved landmark identification and measurement accuracy comparable to inter-radiologist variability, generating results in an average of 8 minutes per patient.
Open in Who Shared View Duplicates (8) Issue with article?

FTC’s noncompete ban is dead, but its efforts to limit noncompetes survives

|
By Barry Rosen, Charles R. Bacharach
| The Daily Record (Baltimore, MD) Verified
In 2024, the Federal Trade Commission promulgated a nationwide rule banning most non-competition agreements. After more than a year of litigation holding up enforcement of the FTC’s rule, the Trump administration, on September 5, 2025, announced that it would dismiss its attempts to overturn the injunctions that ban the enforcement of the rule.
Open in Who Shared Issue with article?

Gender-affirming care guidelines bring complex issues

|
By Barry Rosen
| The Daily Record (Baltimore, MD) Verified
In June 2025, the U.S. Supreme Court upheld Tennessee’s law banning certain gender-affirming medical treatments for minors in U.S. v. Skrmetti. The decision grants states significant discretion to regulate such treatments regardless of a medical provider’s determination that such a course of action is medically appropriate. Tennessee SB1 In 2023, Tennessee passed SB1, which prohibits the use of puberty blockers or hormone therapy for transgender teens.
Open in Who Shared Issue with article?
See all 169 licensed articles (180 Total)